Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Repurchase of Common Stock

Aquestive Therapeutics Inc Repurchase of Common Stock Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Repurchase of Common Stock from 2018 to 2018.
  • Aquestive Therapeutics Inc Repurchase of Common Stock for the quarter ending September 09, 2018 was $0m
  • Aquestive Therapeutics Inc Repurchase of Common Stock for the last 12 months ending September 09, 2018 was $-6m
Other Cash Flow Metrics:
  • Aquestive Therapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a 35.43% decrease of -4m year over year
  • Aquestive Therapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-6m a 59.44% decrease of -4m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Repurchase of Common Stock Data

09/2018$0m
06/2018$-6m